Company / Interest Expense
Organon & Co. Interest Expense History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$504.0M
FY2025
5-year range
$0 / $527.0M
FY2021-FY2025
Trend
-3.1%
vs FY2024
Sector context
#6 of 44
Health Care
What the data says
Organon & Co.'s interest expense of $504M is higher than 86% of companies in the Health Care sector (FY2025). Improved from $527M to $504M over the past 2 years.
Based on SEC 10-K filings.
$504M in FY2025 with a 3-year CAGR of +6.1%. Top quartile in the Health Care sector.
Improved from $527M to $504M over the past 2 years.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- +6.1%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 14% in Health CareTop 86% of 44This company $504.0M Sector average $291.0M
▼
+73.2% above sector average
Key checks
Key Insights
- 3-year CAGR of +6.1%, indicating consistent growth.
- In FY2025, interest expense decreased 3.1% year-over-year.
- Ranks #6 out of 44 companies in the Health Care sector.
- Peak interest expense was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score 0.69 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
- Strong return on equity: 55.3%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $504.0M | -3.1% |
| FY2024 | $520.0M | -1.3% |
| FY2023 | $527.0M | +24.9% |
| FY2022 | $422.0M | - |
| FY2021 | $0 | - |
| FY2020 | $0 | - |
| FY2019 | $0 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026